Skip to main content
. 2017 Nov 30;7:16650. doi: 10.1038/s41598-017-16932-y

Figure 2.

Figure 2

CRISPR/Cas9 works efficiently in naïve human embryonic stem cells. Editing efficiencies for TUNA, EMX1 and MEG3 after transfecting pX335, pX330-sgRNA1 or pX330-sgRNA2 plasmids in the naïve hESCs. As a control, mock-treated naïve hESCs (no plasmid) were used. Grey dots represent two biological replicates, the asterisk indicates the average of both replicates.